ArticleFrontiers in psychiatry2026
Study protocol for the Danish High Risk and Resilience Study VIA 19 - from age 15 to age 19: transition from adolescence to early adulthood.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Longitudinal clinical cohorts following individuals, who are born to parents with severe mental illness, from childhood into adulthood, provide invaluable insight into development of psychopathology, illness course over time and risk and resilience factors. Further, initiatives to prevent mental illness and support families at risk can be inspired and informed. The Danish High Risk and Resilience Study - the VIA cohort was founded during 2013-2015, where 522 7-year-old individuals born to parents with either schizophrenia bipolar disorder or controls, were recruited together with their parents and thoroughly examined. This study protocol presents the VIA 19 study, which is the fourth wave of the study investigating mental health and neurodevelopment in the 19-year-old participants, now in early adulthood. Method and design: Participants are invited to the clinic for a two-day assessment going through a clinical test battery, resembling that of the former waves and following up on previously selected major primary outcomes including daily functioning and social status, neurocognition, social cognition, mental health status, motor function, risk behavior among many other factors. Additionally, the young adults are invited to participate in neuroimaging, sleep assessment and provide samples of biological and genetic markers. Results: The data collection started in August 2024. A large effort is put into reaching all the young adults to ensure a high retention rate resembling the rates from the former waves ranging between 82 and 89%. Discussion: At age 19 we expect several full manifestations of first episode schizophrenia or bipolar disorder. Due to the longitudinal design, we will be able to draw trajectories of various kinds of outcomes and thus pinpoint developmental pathways from childhood to early adulthood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.